{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:11:42Z","timestamp":1786990302494,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T00:00:00Z","timestamp":1710288000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2023\/01331-2"],"award-info":[{"award-number":["2023\/01331-2"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2021\/11606-3"],"award-info":[{"award-number":["2021\/11606-3"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2022\/03316-8"],"award-info":[{"award-number":["2022\/03316-8"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2020\/12842-0"],"award-info":[{"award-number":["2020\/12842-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Hematology, Transfusion and Cell Therapy"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.htct.2024.02.017","type":"journal-article","created":{"date-parts":[[2024,3,21]],"date-time":"2024-03-21T10:55:14Z","timestamp":1711018514000},"page":"S112-S121","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"S6","title":["NT157 exhibits antineoplastic effects by targeting IRS and STAT3\/5 signaling in multiple myeloma"],"prefix":"10.1016","volume":"46","author":[{"given":"Gustavo Nery","family":"de Queiroz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keli","family":"Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia Bassani Lins","family":"de Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo Magalh\u00e3es","family":"Rego","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiola","family":"Traina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2937-8109","authenticated-orcid":false,"given":"Jo\u00e3o Agostinho","family":"Machado-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.htct.2024.02.017_bib0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21708","article-title":"Cancer statistics, 2022","volume":"72","author":"Siegel","year":"2022","journal-title":"CA Cancer J Clin"},{"issue":"9","key":"10.1016\/j.htct.2024.02.017_bib0002","doi-asserted-by":"crossref","first-page":"e1406","DOI":"10.1634\/theoncologist.2020-0141","article-title":"Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment","volume":"25","author":"Ludwig","year":"2020","journal-title":"Oncologist"},{"issue":"7","key":"10.1016\/j.htct.2024.02.017_bib0003","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1182\/blood-2018-09-825331","article-title":"Toward personalized treatment in multiple myeloma based on molecular characteristics","volume":"133","author":"Pawlyn","year":"2019","journal-title":"Blood"},{"issue":"7","key":"10.1016\/j.htct.2024.02.017_bib0004","first-page":"430","article-title":"Current frontline treatment of multiple myeloma","volume":"36","author":"Holstein","year":"2022","journal-title":"Oncology"},{"key":"10.1016\/j.htct.2024.02.017_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101116","article-title":"Aiming for the cure in myeloma: putting our best foot forward","author":"Bar","year":"2023","journal-title":"Blood Rev"},{"issue":"6","key":"10.1016\/j.htct.2024.02.017_bib0006","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1182\/blood.V88.6.2250.bloodjournal8862250","article-title":"Insulin-like growth factor I is a growth and survival factor in human multiple myeloma cell lines","volume":"88","author":"Georgii-Hemming","year":"1996","journal-title":"Blood"},{"issue":"19","key":"10.1016\/j.htct.2024.02.017_bib0007","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.1182\/blood-2008-07-170464","article-title":"The role of IGF-1 as a major growth factor for myeloma cell lines and the prognostic relevance of the expression of its receptor","volume":"113","author":"Sprynski","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.htct.2024.02.017_bib0008","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1182\/blood-2003-06-2066","article-title":"Insulin-like growth factor I induces migration and invasion of human multiple myeloma cells","volume":"103","author":"Qiang","year":"2004","journal-title":"Blood"},{"issue":"18","key":"10.1016\/j.htct.2024.02.017_bib0009","first-page":"5850","article-title":"Insulin-like growth factor-1 induces adhesion and migration in human multiple myeloma cells via activation of beta1-integrin and phosphatidylinositol 3\u2032-kinase\/AKT signaling","volume":"63","author":"Tai","year":"2003","journal-title":"Cancer Res"},{"issue":"7","key":"10.1016\/j.htct.2024.02.017_bib0010","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.exphem.2013.03.002","article-title":"HGF and IGF-1 synergize with SDF-1alpha in promoting migration of myeloma cells by cooperative activation of p21-activated kinase","volume":"41","author":"Ro","year":"2013","journal-title":"Exp Hematol"},{"issue":"12","key":"10.1016\/j.htct.2024.02.017_bib0011","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1182\/blood-2002-05-1406","article-title":"Serum insulinlike growth factor is not elevated in patients with multiple myeloma but is still a prognostic factor","volume":"100","author":"Standal","year":"2002","journal-title":"Blood"},{"issue":"14","key":"10.1016\/j.htct.2024.02.017_bib0012","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1158\/0008-5472.CAN-12-3385","article-title":"Therapeutic destruction of insulin receptor substrates for cancer treatment","volume":"73","author":"Reuveni","year":"2013","journal-title":"Cancer Res"},{"issue":"20","key":"10.1016\/j.htct.2024.02.017_bib0013","doi-asserted-by":"crossref","first-page":"2675","DOI":"10.1038\/onc.2015.229","article-title":"Targeting melanoma with NT157 by blocking Stat3 and IGF1R signaling","volume":"35","author":"Flashner-Abramson","year":"2016","journal-title":"Oncogene"},{"issue":"20","key":"10.1016\/j.htct.2024.02.017_bib0014","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1038\/onc.2015.326","article-title":"Targeting colorectal cancer via its microenvironment by inhibiting IGF-1 receptor-insulin receptor substrate and STAT3 signaling","volume":"35","author":"Sanchez-Lopez","year":"2016","journal-title":"Oncogene"},{"issue":"1","key":"10.1016\/j.htct.2024.02.017_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41392-019-0102-5","article-title":"NT157 has antineoplastic effects and inhibits IRS1\/2 and STAT3\/5 in JAK2(V617F)-positive myeloproliferative neoplasm cells","volume":"5","author":"Fenerich","year":"2020","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"10.1016\/j.htct.2024.02.017_bib0016","doi-asserted-by":"crossref","first-page":"17092","DOI":"10.1038\/s41598-022-21419-6","article-title":"NT157 exerts antineoplastic activity by targeting JNK and AXL signaling in lung cancer cells","volume":"12","author":"de Miranda","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.htct.2024.02.017_bib0017","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2019.04.030","article-title":"IGF1R\/IRS1 targeting has cytotoxic activity and inhibits PI3K\/AKT\/mTOR and MAPK signaling in acute lymphoblastic leukemia cells","volume":"456","author":"Rodrigues Alves","year":"2019","journal-title":"Cancer Lett"},{"issue":"3","key":"10.1016\/j.htct.2024.02.017_bib0018","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1007\/s10637-020-01028-8","article-title":"NT157, an IGF1R-IRS1\/2 inhibitor, exhibits antineoplastic effects in pre-clinical models of chronic myeloid leukemia","volume":"39","author":"Scopim-Ribeiro","year":"2021","journal-title":"Invest New Drugs"},{"key":"10.1016\/j.htct.2024.02.017_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2022.105384","article-title":"Differential cytotoxic activity of pharmacological inhibitors of IGF1R-related pathways in JAK2(V617F) driven cells","volume":"83","author":"Fernandes","year":"2022","journal-title":"Toxicol In Vitro"},{"issue":"12","key":"10.1016\/j.htct.2024.02.017_bib0020","doi-asserted-by":"crossref","first-page":"2827","DOI":"10.1158\/1535-7163.MCT-13-0842","article-title":"The tyrphostin NT157 suppresses insulin receptor substrates and augments therapeutic response of prostate cancer","volume":"13","author":"Ibuki","year":"2014","journal-title":"Mol Cancer Ther"},{"issue":"74","key":"10.1016\/j.htct.2024.02.017_bib0021","article-title":"Preclinical effectiveness of selective inhibitor of IRS-1\/2 NT157 in osteosarcoma cell lines","volume":"6","author":"Garofalo","year":"2015","journal-title":"Front Endocrinol"},{"issue":"5","key":"10.1016\/j.htct.2024.02.017_bib0022","first-page":"7000","article-title":"IGF-1-induced MMP-11 expression promotes the proliferation and invasion of gastric cancer cells through the JAK1\/STAT3 signaling pathway","volume":"15","author":"Su","year":"2018","journal-title":"Oncol Lett"},{"issue":"6","key":"10.1016\/j.htct.2024.02.017_bib0023","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12672-018-0343-8","article-title":"Insulin receptor substrate suppression by the tyrphostin NT157 inhibits responses to insulin-like growth factor-I and insulin in breast cancer cells","volume":"9","author":"Yang","year":"2018","journal-title":"Horm Cancer"},{"key":"10.1016\/j.htct.2024.02.017_bib0024","doi-asserted-by":"crossref","DOI":"10.1177\/15330338211027916","article-title":"NT157 inhibits HCC migration via downregulating the STAT3\/Jab1 signaling pathway","volume":"20","author":"Yu","year":"2021","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.htct.2024.02.017_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113502","article-title":"NT157 inhibits cell proliferation and sensitizes glioma cells to TRAIL-induced apoptosis by up-regulating DR5 expression","volume":"153","author":"Hou","year":"2022","journal-title":"Biomed Pharmacother"},{"issue":"4","key":"10.1016\/j.htct.2024.02.017_bib0026","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/kjm2.12652","article-title":"Repressing IRS1\/2 by NT157 inhibits the malignant behaviors of ovarian cancer through inactivating PI3K\/AKT\/mTOR pathway and inducing autophagy","volume":"39","author":"Li","year":"2023","journal-title":"Kaohsiung J Med Sci"},{"issue":"24","key":"10.1016\/j.htct.2024.02.017_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14246247","article-title":"Targeting IRS-1\/2 in uveal melanoma inhibits in vitro cell growth, survival and migration, and in vivo tumor growth","volume":"14","author":"Chattopadhyay","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.htct.2024.02.017_bib0028","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2174\/1875036201004010005","article-title":"Amazonia!: an online resource to google and visualize public human whole genome expression data","volume":"4","author":"Carrour","year":"2010","journal-title":"Open Bioinform J"},{"issue":"4","key":"10.1016\/j.htct.2024.02.017_bib0029","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"issue":"2","key":"10.1016\/j.htct.2024.02.017_bib0030","doi-asserted-by":"crossref","first-page":"374","DOI":"10.2144\/03342mt01","article-title":"TM4: a free, open-source system for microarray data management and analysis","volume":"34","author":"Saeed","year":"2003","journal-title":"Biotechniques"},{"issue":"14","key":"10.1016\/j.htct.2024.02.017_bib0031","first-page":"3909","article-title":"Activation of insulin-like growth factor I receptor signaling pathway is critical for mouse plasma cell tumor growth","volume":"60","author":"Li","year":"2000","journal-title":"Cancer Res"},{"issue":"8","key":"10.1016\/j.htct.2024.02.017_bib0032","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1182\/blood.V96.8.2856","article-title":"Insulin-like growth factor I is a dual effector of multiple myeloma cell growth","volume":"96","author":"Ge","year":"2000","journal-title":"Blood"},{"issue":"30","key":"10.1016\/j.htct.2024.02.017_bib0033","doi-asserted-by":"crossref","first-page":"48732","DOI":"10.18632\/oncotarget.8982","article-title":"The insulin-like growth factor system in multiple myeloma: diagnostic and therapeutic potential","volume":"7","author":"Bieghs","year":"2016","journal-title":"Oncotarget"},{"issue":"suppl 1","key":"10.1016\/j.htct.2024.02.017_bib0034","doi-asserted-by":"crossref","first-page":"e566s","DOI":"10.6061\/clinics\/2018\/e566s","article-title":"Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis","volume":"73","author":"Machado-Neto","year":"2018","journal-title":"Clinics"},{"issue":"1","key":"10.1016\/j.htct.2024.02.017_bib0035","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23010048","article-title":"Ribosomal protein S6: a potential therapeutic target against cancer?","volume":"23","author":"Yi","year":"2021","journal-title":"Int J Mol Sci"},{"issue":"1","key":"10.1016\/j.htct.2024.02.017_bib0036","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/s41375-019-0543-4","article-title":"MYC dysregulation in the progression of multiple myeloma","volume":"34","author":"Misund","year":"2020","journal-title":"Leukemia"},{"issue":"6","key":"10.1016\/j.htct.2024.02.017_bib0037","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1038\/s41375-018-0036-x","article-title":"Targeting MYC in multiple myeloma","volume":"32","author":"Jovanovic","year":"2018","journal-title":"Leukemia"},{"key":"10.1016\/j.htct.2024.02.017_bib0038","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3389\/fonc.2018.00533","article-title":"Role and regulation of pro-survival BCL-2 proteins in multiple myeloma","volume":"8","author":"Slomp","year":"2018","journal-title":"Front Oncol"},{"issue":"9","key":"10.1016\/j.htct.2024.02.017_bib0039","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41375-018-0223-9","article-title":"Targeting Bcl-2 for the treatment of multiple myeloma","volume":"32","author":"Touzeau","year":"2018","journal-title":"Leukemia"},{"issue":"3","key":"10.1016\/j.htct.2024.02.017_bib0040","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/S1097-2765(01)00214-3","article-title":"PUMA, a novel proapoptotic gene, is induced by p53","volume":"7","author":"Nakano","year":"2001","journal-title":"Mol Cell"},{"issue":"20","key":"10.1016\/j.htct.2024.02.017_bib0041","doi-asserted-by":"crossref","first-page":"11318","DOI":"10.1073\/pnas.201208798","article-title":"Expression of bbc3, a pro-apoptotic BH3-only gene, is regulated by diverse cell death and survival signals","volume":"98","author":"Han","year":"2001","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"10.1016\/j.htct.2024.02.017_bib0042","doi-asserted-by":"crossref","first-page":"S84","DOI":"10.1038\/onc.2009.46","article-title":"Noxa: at the tip of the balance between life and death","volume":"27","author":"Ploner","year":"2008","journal-title":"Oncogene"}],"container-title":["Hematology, Transfusion and Cell Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2531137924000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T06:06:38Z","timestamp":1737957998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2531137924000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":42,"alternative-id":["S2531137924000622"],"URL":"https:\/\/doi.org\/10.1016\/j.htct.2024.02.017","relation":{},"ISSN":["2531-1379"],"issn-type":[{"value":"2531-1379","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NT157 exhibits antineoplastic effects by targeting IRS and STAT3\/5 signaling in multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Hematology, Transfusion and Cell Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.htct.2024.02.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Associa\u00e7\u00e3o Brasileira de Hematologia, Hemoterapia e Terapia Celular. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}